ProChondrix

AlloSource Granted Patent for Proprietary Laser Cutting Enclosure

Centennial, Colo. — November 16, 2018 — AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, received U.S. patent 10,105,793, titled Enclosure for laser cutting of human tissue. This patent encompasses AlloSource’s method of producing a closed system that allows a laser beam to pass through and etch allograft tissue, while maintaining a sterile barrier. The proprietary method expedites processing, maximizes the use of tissue, and allows utilization of a specialized laser technology in a clean room setting. The process is used to create ProChondrix® CR, AlloSource’s fresh cryopreserved osteochondral allograft. ProChondrix CR…

AlloSource Announces Two Presentations on ProChondrix at the International Cartilage Repair Society World Congress

Centennial, Colo. — April 10, 2018 — AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, today announced that clinical and scientific data on its ProChondrix® osteochondral allograft will be presented at the International Cartilage Repair Society’s 14th World Congress on Wednesday, April 11 from 13:00-14:00 in the Almaty 3 Room. Dr. Vishal Mehta will present his 24-month clinical experience with ProChondrix in the knee. Dr. Mehta performed the first ProChondrix implantation in December of 2014 and will share his clinical experience with the product. “ProChondrix has been a valuable addition to my…

AlloSource and Stryker Launch ProChondrix CR Cryopreserved Osteochondral Allograft

Centennial, Colo. – April 4, 2018 – AlloSource and Stryker today announced the launch of ProChondrix® CR, a cryopreserved osteochondral allograft. ProChondrix CR is a single-stage, natural solution for patients in need of articular cartilage repair. ProChondrix CR is designed to match biomechanical and biochemical properties of normal hyaline cartilage, restore a smooth articular cartilage surface, help relieve patient symptoms, and improve function. AlloSource launched ProChondrix in 2016 and developed a cryopreserved version to provide a longer shelf-life, while maintaining the high cellular viability of the product1. “ProChondrix CR demonstrates our commitment to innovation and our surgeon customers,” said Kerr…

International Cartilage Repair Society Symposia To Highlight Early Findings Of ProChondrix Cartilage Restoration Matrix

Centennial, Colo. — September 23, 2016 — AlloSource, one of the nation’s largest providers of cartilage, cellular, bone, skin and soft-tissue allografts for use in surgical procedures and wound care to advance patient healing, will share early results of its fresh cartilage allograft, ProChondrix® Cartilage Restoration Matrix during the International Cartilage Repair Society’s (ICRS) 13th World Congress in Sorrento-Naples, Italy. The Industry Satellite Lunch Symposia will take place on Monday, 26 September 2016 from 13:00 to 13:30 in the Sala Nettuna Room. Vishal Mehta, M.D., orthopedic surgeon from Fox Valley Orthopedics in Geneva, Illinois, will present early results of ProChondrix…

AlloSource Receives Orthopedics This Week Sports Medicine Award For ProChondrix Cartilage Restoration Matrix

Centennial, Colo. — July 7, 2016 — AlloSource, one of the nation’s largest providers of cartilage, cellular, bone, skin and soft-tissue allografts for use in surgical procedures and wound care to advance patient healing, today announced that it received Orthopedics This Week’s first annual Sports Medicine Award for its fresh cartilage allograft, ProChondrix®. The First Annual Sports Medicine Award recognizes engineering excellence, innovation and advancement of sports medicine. Orthopedics This Week presented awards in three technology categories: Diagnostic/Monitoring/Fitness Measurement, Rehabilitation, and Surgical Implants and Instruments. ProChondrix received an award in the Surgical Implant and Instrument category. “ProChondrix was inspired by…

AlloSource Launches ProChondrix Cartilage Restoration Matrix For Repair And Regeneration Of Cartilage

Centennial, Colo. — March 1, 2016 — AlloSource®, one of the nation’s largest providers of cartilage, cellular, bone, skin and soft-tissue allografts for use in surgical procedures and wound care to advance patient healing, announced today the launch of ProChondrix® Cartilage Restoration Matrix, a cellular 3D fresh cartilage allograft helping to provide the necessary components for cartilage regeneration. This patented, next generation of cartilage therapy is designed to match biomechanical and biochemical properties of normal hyaline cartilage, restore a smooth articular cartilage surface and relieve patient symptoms and improve function. “One of the most important ways we honor tissue donors…

AlloSource’s New Cartilage Repair Product, ProChondrix, Receives Patent

Centennial, Colo. — January 19, 2016 — AlloSource®, one of the nation’s largest providers of cartilage, cellular, bone, skin and soft-tissue allografts for use in surgical procedures and wound care to advance patient healing, was awarded U.S. Patent Number 9,186,253, titled Cartilage mosaic compositions and methods, for its new cartilage repair allograft, ProChondrix® Cartilage Restoration Matrix. ProChondrix is a cellular 3D fresh cartilage matrix that helps deliver the necessary components for cartilage restoration. This next generation of cartilage therapy provides live functional cells and other biological components necessary for repair and regeneration of damaged cartilage tissues. “With thousands of cartilage…